Amphastar Pharmaceuticals Inc
AMPH21.010USD
-0.200-0.94%
交易中 （美东）报价延迟15分钟
1.00B总市值
7.07市盈率 TTM
关于 Amphastar Pharmaceuticals Inc 公司
Amphastar Pharmaceuticals, Inc. 是一家生物制药公司，主要专注于开发、制造、营销和销售具有技术挑战性的仿制药和注射剂、吸入剂和鼻内剂产品。此外，该公司还销售胰岛素 API 产品。其大部分成品用于医院或紧急护理临床环境，主要通过集团采购组织和药品批发商签约和分销。其部门包括成品药品和 API 产品。成品药品部门制造、营销和分销 Primatene MIST、肾上腺素、胰高血糖素、植物萘醌、利多卡因、依诺肝素、纳洛酮以及其他各种重症和非重症护理药物。API 部门为外部客户和内部产品开发制造和分销 RHI API 和猪胰岛素 API。其产品线有 20 多种候选产品，包括仿制药 ANDA、生物仿制药等。
公司简介
公司代码AMPH
公司名称Amphastar Pharmaceuticals Inc
上市日期Jun 25, 2014
CEODr. Yongfeng (Jack) Zhang, Ph.D.
员工数量2028
证券类型Ordinary Share
年结日Jun 25
公司地址11570 6th St
城市RANCHO CUCAMONGA
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编91730
电话19099809484
网址https://amphastar.com/
公司代码AMPH
上市日期Jun 25, 2014
CEODr. Yongfeng (Jack) Zhang, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Rong Zhou
Mr. Rong Zhou
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
197.10K
+5.69%
Dr. Howard S. Lee, Ph.D.
Dr. Howard S. Lee, Ph.D.
Independent Director
Independent Director
148.90K
+2.90%
Mr. Floyd F. Petersen
Mr. Floyd F. Petersen
Independent Director
Independent Director
74.45K
-0.67%
Mr. William J. Peters
Mr. William J. Peters
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
55.44K
-0.49%
Mr. Richard K. Prins
Mr. Richard K. Prins
Lead Independent Director
Lead Independent Director
32.11K
+18.98%
Ms. Gayle Deflin
Ms. Gayle Deflin
Independent Director
Independent Director
7.84K
+188.59%
Mr. Jacob Liawatidewi
Mr. Jacob Liawatidewi
Executive Vice President of Sales and Marketing, Corporate Administration Center, President of Amphastar France Pharmaceuticals, S.A.S, Company Secretary, Director
Executive Vice President of Sales and Marketing, Corporate Administration Center, President of Amphastar France Pharmaceuticals, S.A.S, Company Secretary, Director
--
--
Mr. Dan Dischner
Mr. Dan Dischner
Vice President - Corporate Communications
Vice President - Corporate Communications
--
--
Ms. Diane G. Gerst
Ms. Diane G. Gerst
Independent Director
Independent Director
--
--
Mr. David Gaugh
Mr. David Gaugh
Director
Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Rong Zhou
Mr. Rong Zhou
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
197.10K
+5.69%
Dr. Howard S. Lee, Ph.D.
Dr. Howard S. Lee, Ph.D.
Independent Director
Independent Director
148.90K
+2.90%
Mr. Floyd F. Petersen
Mr. Floyd F. Petersen
Independent Director
Independent Director
74.45K
-0.67%
Mr. William J. Peters
Mr. William J. Peters
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
55.44K
-0.49%
Mr. Richard K. Prins
Mr. Richard K. Prins
Lead Independent Director
Lead Independent Director
32.11K
+18.98%
Ms. Gayle Deflin
Ms. Gayle Deflin
Independent Director
Independent Director
7.84K
+188.59%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
暂无数据
地区USD
名称
营收
占比
United States
162.59M
95.35%
France
7.86M
4.61%
China
81.00K
0.05%
业务
地区
暂无数据
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
Applied Physics & Chemistry Laboratories, Inc.
14.48%
BlackRock Institutional Trust Company, N.A.
11.72%
Zhang (Jack Yongfeng)
5.57%
The Vanguard Group, Inc.
5.12%
TD Asset Management Inc.
4.32%
Other
58.79%
持股股东
持股股东
占比
Applied Physics & Chemistry Laboratories, Inc.
14.48%
BlackRock Institutional Trust Company, N.A.
11.72%
Zhang (Jack Yongfeng)
5.57%
The Vanguard Group, Inc.
5.12%
TD Asset Management Inc.
4.32%
Other
58.79%
股东类型
持股股东
占比
Investment Advisor
41.31%
Investment Advisor/Hedge Fund
22.63%
Corporation
14.48%
Individual Investor
9.20%
Hedge Fund
6.05%
Research Firm
1.44%
Pension Fund
0.97%
Bank and Trust
0.32%
Sovereign Wealth Fund
0.11%
Other
3.48%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
601
45.52M
96.57%
-3.82M
2025Q1
611
45.81M
97.08%
-3.30M
2024Q4
605
46.57M
97.74%
-2.04M
2024Q3
587
46.65M
96.28%
-609.11K
2024Q2
577
45.56M
93.11%
-1.23M
2024Q1
560
44.76M
91.63%
-1.31M
2023Q4
542
44.44M
92.40%
-767.71K
2023Q3
510
43.50M
90.64%
-1.16M
2023Q2
483
43.02M
88.37%
-388.11K
2023Q1
456
42.07M
87.29%
-710.60K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Applied Physics & Chemistry Laboratories, Inc.
6.83M
14.48%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.52M
11.72%
-66.62K
-1.19%
Mar 31, 2025
Zhang (Jack Yongfeng)
2.62M
5.57%
+200.00K
+8.25%
Jun 13, 2025
The Vanguard Group, Inc.
2.41M
5.12%
-291.72K
-10.78%
Mar 31, 2025
TD Asset Management Inc.
2.21M
4.69%
+371.86K
+20.21%
Mar 31, 2025
State Street Global Advisors (US)
1.60M
3.4%
+8.50K
+0.53%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.36M
2.88%
+157.77K
+13.16%
Mar 31, 2025
Fuller & Thaler Asset Management Inc.
1.26M
2.68%
+130.67K
+11.53%
Mar 31, 2025
Epoch Investment Partners, Inc.
1.26M
2.68%
+160.03K
+14.53%
Mar 31, 2025
Boston Trust Walden Company
1.22M
2.58%
+236.70K
+24.18%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Invesco Pharmaceuticals ETF
2.43%
SPDR S&P Pharmaceuticals ETF
1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.36%
Invesco S&P SmallCap 600 GARP ETF
0.99%
Acquirers Small and Micro Deep Value ETF
0.92%
Invesco S&P SmallCap Health Care ETF
0.6%
iShares U.S. Pharmaceuticals ETF
0.42%
Distillate Small/Mid Cash Flow ETF
0.42%
First Trust Small Cap Value AlphaDEX Fund
0.41%
VictoryShares Small Cap Free Cash Flow ETF
0.39%
查看更多
Invesco Pharmaceuticals ETF
占比2.43%
SPDR S&P Pharmaceuticals ETF
占比1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比1.36%
Invesco S&P SmallCap 600 GARP ETF
占比0.99%
Acquirers Small and Micro Deep Value ETF
占比0.92%
Invesco S&P SmallCap Health Care ETF
占比0.6%
iShares U.S. Pharmaceuticals ETF
占比0.42%
Distillate Small/Mid Cash Flow ETF
占比0.42%
First Trust Small Cap Value AlphaDEX Fund
占比0.41%
VictoryShares Small Cap Free Cash Flow ETF
占比0.39%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
